readthroughSign in
CompanyAVBPNasdaqNewtown Square, PA

ArriVent BioPharma, Inc.

ArriVent develops small-molecule and antibody-drug conjugate therapeutics for cancer.

10-QNov 16Latest SEC filing
Nov 9Latest story